GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (OTCPK:AKESF) » Definitions » Short-Term Debt

Akeso (AKESF) Short-Term Debt : $73.5 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Akeso Short-Term Debt?

Akeso's Short-Term Debt for the quarter that ended in Dec. 2024 was $73.5 Mil.

Akeso's quarterly Short-Term Debt declined from Dec. 2023 ($54.7 Mil) to Jun. 2024 ($37.6 Mil) but then increased from Jun. 2024 ($37.6 Mil) to Dec. 2024 ($73.5 Mil).

Akeso's annual Short-Term Debt declined from Dec. 2022 ($64.0 Mil) to Dec. 2023 ($54.7 Mil) but then increased from Dec. 2023 ($54.7 Mil) to Dec. 2024 ($73.5 Mil).

Akeso Short-Term Debt Historical Data

The historical data trend for Akeso's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akeso Short-Term Debt Chart

Akeso Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Debt
Get a 7-Day Free Trial 2.11 7.16 63.97 54.69 73.55

Akeso Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.97 42.45 54.69 37.58 73.55

Akeso Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Akeso Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Akeso's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Akeso Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (OTCPK:AKESF) » Definitions » Short-Term Debt
Comparable Companies
HKSE:01801 HKSE:02269 HKSE:01177 HKSE:06990 HKSE:01877 HKSE:09995 HKSE:01530 HKSE:01548 HKSE:02696 HKSE:09969 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
09926:Hong Kong 4RY:Germany
Address
6 Shennong Road, Torch Development Zone, Guangdong Province, Zhongshan, CHN, 528437
Website
https://www.akesobio.com
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation, and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in USA.